Work

Abstract 5000: Cell cycle checkpoint kinase (CHK)1 inhibition induces immune modulation in recurrentBRCAwild-type high-grade serous ovarian cancer (HGSOC) patients

Year: 2019

Type: conference-abstract

Source: Clinical Research (Excluding Clinical Trials)

DOI: 10.1158/1538-7445.sabcs18-5000

Authors: Erika J. Lampert, Min-Jung Lee, Jane B. Trepel, Akira Yuno, Ashley Cimino-Mathews, Joo-Sang Lee, Eytan Ruppin, Jayakumar Nair, Irene Ekwede, Jung-Min Lee

Institutions: National Institutes of Health, National Cancer Institute, Center for Cancer Research, Johns Hopkins Hospital

Language: English

Topic: Ovarian cancer diagnosis and treatment

Subfield: Reproductive Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4243791187

Cites:

Cited by: 1

Related to: 10